HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 106 filers reported holding HOMOLOGY MEDICINES INC in Q3 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 490 | -69.7% | 0.00% | – |
| Q1 2023 | $1 | -94.4% | 1,616 | -89.1% | 0.00% | – |
| Q4 2022 | $18 | -99.9% | 14,759 | -1.8% | 0.00% | – |
| Q3 2022 | $24,000 | -65.2% | 15,025 | -57.4% | 0.00% | – |
| Q2 2022 | $69,000 | +76.9% | 35,293 | +169.8% | 0.00% | – |
| Q1 2022 | $39,000 | +178.6% | 13,082 | +224.5% | 0.00% | – |
| Q4 2021 | $14,000 | -75.4% | 4,032 | -47.4% | 0.00% | – |
| Q3 2021 | $57,000 | +1.8% | 7,667 | -2.2% | 0.00% | – |
| Q2 2021 | $56,000 | -12.5% | 7,838 | +14.8% | 0.00% | – |
| Q1 2021 | $64,000 | +392.3% | 6,828 | +483.6% | 0.00% | – |
| Q4 2020 | $13,000 | -89.3% | 1,170 | -89.7% | 0.00% | – |
| Q3 2020 | $121,000 | +152.1% | 11,310 | +255.4% | 0.00% | – |
| Q2 2020 | $48,000 | +20.0% | 3,182 | +21.8% | 0.00% | – |
| Q1 2020 | $40,000 | +81.8% | 2,612 | +141.9% | 0.00% | – |
| Q4 2019 | $22,000 | +2100.0% | 1,080 | +1670.5% | 0.00% | – |
| Q3 2019 | $1,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 5,535,919 | $86,028,000 | 26.64% |
| VV Manager LLC | 770,845 | $11,979,000 | 13.54% |
| RTW INVESTMENTS, LP | 4,399,250 | $68,364,000 | 2.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,037,305 | $62,740,000 | 1.99% |
| COWEN AND COMPANY, LLC | 476,488 | $7,405,000 | 1.70% |
| Vivo Capital, LLC | 1,008,562 | $15,673,000 | 1.42% |
| Ghost Tree Capital, LLC | 200,000 | $3,108,000 | 0.82% |
| Bellevue Group AG | 1,612,122 | $25,052,000 | 0.49% |
| Cormorant Asset Management, LP | 600,000 | $9,324,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $50,043,000 | 0.37% |